Edwards Lifesciences (EW) Change in Acquisitions & Divestments (2016 - 2026)
Edwards Lifesciences has reported Change in Acquisitions & Divestments over the past 16 years, most recently at -$2.0 billion for Q4 2025.
- For Q4 2025, Change in Acquisitions & Divestments fell 884.41% year-over-year to -$2.0 billion; the TTM value through Dec 2025 reached $62.1 million, down 92.24%, while the annual FY2025 figure was $62.1 million, 92.24% down from the prior year.
- Change in Acquisitions & Divestments for Q4 2025 was -$2.0 billion at Edwards Lifesciences, down from $669.7 million in the prior quarter.
- Over five years, Change in Acquisitions & Divestments peaked at $1.4 billion in Q2 2025 and troughed at -$2.0 billion in Q4 2025.
- A 5-year average of $107.2 million and a median of $95.0 million in 2022 define the central range for Change in Acquisitions & Divestments.
- Biggest five-year swings in Change in Acquisitions & Divestments: surged 12536.67% in 2024 and later crashed 884.41% in 2025.
- Year by year, Change in Acquisitions & Divestments stood at $128.0 million in 2021, then dropped by 25.78% to $95.0 million in 2022, then skyrocketed by 454.11% to $526.4 million in 2023, then tumbled by 50.42% to $261.0 million in 2024, then crashed by 884.41% to -$2.0 billion in 2025.
- Business Quant data shows Change in Acquisitions & Divestments for EW at -$2.0 billion in Q4 2025, $669.7 million in Q3 2025, and $1.4 billion in Q2 2025.